|
|
|
| Research progress of m6A modification in gastric cancer#br# |
| XIE Shengmao1 ZHANG Zhilong2 LI Chunhui3 SHI Fei4 |
1.Department of Gastroenterology, NO.969 Hospital, the Chinese People’s Liberation Army Joint Logistic Support Force, Inner Mongolia Autonomous Region, Hohhot 010051, China;
2.Department of General Surgery, NO.969 Hospital, the Chinese People’s Liberation Army Joint Logistic Support Force, Inner Mongolia Autonomous Region, Hohhot 010051, China;
3.Department of Respiratory and Critical Care Medicine, Inner Mongolia People’s Hospital, Inner Mongolia Autonomous Region, Hohhot 010010, China; 4.School of Medicine of Aeronautics and Astronautics, the Chinese People’s Liberation Army Air Force Medical University, Shaanxi Province, Xi’an 710032, China |
|
|
|
Abstract Gastric cancer is the most common gastrointestinal tumor in China, and its therapeutic effect is not good. More than 150 kinds of RNA modifications have been discovered, and the dynamic modification of m6A is the most abundant one in RNA modification. m6A modification plays an important role in RNA metabolism and is involved in many biological processes such as cell proliferation, differentiation, and apoptosis. m6A modification imbalance also plays an important role in the occurrence and development of gastric cancer, in-depth study of the molecular mechanism of gastric cancer can provide a new strategy for the treatment of gastric cancer.
|
|
|
|
|
|
[1] Kawazoe A，Shitara K，Boku N，et al. Current status of immunotherapy for advanced gastric cancer [J]. Jpn J Clin Oncol，2021，51（1）：20-27.
[2] Xie J，Fu L，Jin L. Immunotherapy of gastric cancer：Past，future perspective and challenges [J]. Pathol Res Pract，2021，218：153322.
[3] Zhang Y，Geng X，Li Q，et al. m6A modification in RNA：biogenesis，functions and roles in gliomas [J]. J Exp Clin Cancer Res，2020，39（1）：192.
[4] Yang C，Hu Y，Zhou B，et al. The role of m6A modification in physiology and disease [J]. Cell Death Dis，2020，11（11）：960.
[5] Zhang C，Zhang M，Ge S，et al. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer [J]. Cancer Med，2019，8（10）：4766-4781.
[6] Huang H，Weng H，Chen J. The Biogenesis and Precise Control of RNA m6A Methylation [J]. Trends Genet，2020， 36（1）：44-52.
[7] Chen J，Du B. Novel positioning from obesity to cancer：FTO，an m6A RNA demethylase，regulates tumour progression [J]. J Cancer Res Clin Oncol，2019，145（1）：19-29.
[8] Jia G，Fu Y，Zhao X，et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO [J]. Nat Chem Biol，2011，7（12）：885-887.
[9] Lasman L，Krupalnik V，Viukov S，et al. Context-dependent functional compensation between Ythdf m6A reader proteins [J]. Genes Dev，2020，34（19/20）：1373-1391.
[10] Yang DD，Chen ZH，Yu K，et al. METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway [J]. Front Oncol，2020，10：115.
[11] Zhou W，Xian Q，Wang Q，et al. m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1 [J]. J Oncol，2021，2021：8875424.
[12] Yang Z，Jiang X，Li D，et al. HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification [J]. Aging（Albany NY），2020，12（24）：24967-24982.
[13] Sun Y，Li S，Yu W，et al. N6-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN/TMEM127 and promotes sensitivity to everolimus in gastric cancer [J]. Cell Death Dis，2020，11（10）：836.
[14] Guan K，Liu X，Li J，et al. Expression status and prognostic value of m6A-associated genes in gastric cancer [J]. J Cancer，2020，11（10）：3027-3040.
[15] Li H，Su Q，Li B，et al. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration [J]. J Cell Mol Med，2020，24（8）：4452-4465.
[16] Wang XK，Zhang YW，Wang CM，et al. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer [J]. J Cell Mol Med，2021，25（14）：6602-6617.
[17] Yu H，Zhao K，Zeng H，et al. N6-methyladenosine methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability [J]. Biomed Pharmacother，2021，133：111075.
[18] Miao R，Dai CC，Mei L，et al. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer [J]. J Cell Physiol，2020，235（10）：7420-7432.
[19] Hu N，Ji H. N6-methyladenosine-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation，migration，and invasion of gastric cancer via miR495-5p/RAB19 axis [J]. Bioengineered，2021，12（1）：4081-4091.
[20] Liu X，Xiao M，Zhang L，et al. The m6A methyltransferase METTL14 inhibits the proliferation，migration，and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway [J]. J Clin Lab Anal，2021，35（3）：e23655.
[21] Guo C，Chu H，Gong Z，et al. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway [J]. Life Sci，2021，278：119522.
[22] Yang Z，Jiang X，Zhang Z，et al. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer [J]. Cancer Gene Ther，2021，28（1/2）：141-155.
[23] Feng S，Qiu G，Yang L，et al. Omeprazole improves che-mosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation [J]. Biosci Rep，2021，41（1）：BSR20200842.
[24] Zhang J，Guo S，Piao HY，et al. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1 [J]. J Physiol Biochem，2019，75（3）：379-389.
[25] Ge L，Zhang N，Chen Z，et al. Level of N6-Methyladenosine in Peripheral Blood RNA：A Novel Predictive Biomarker for Gastric Cancer [J]. Clin Chem，2020，66（2）：342-351.
[26] Hu Y，Fang Z，Mu J，et al. Quantitative Analysis of Methylated Adenosine Modifications Revealed Increased Levels of N6-Methyladenosine（m6A） and N6，2’-O-Dimethyladenosine（m6Am）in Serum From Colorectal Cancer and Gastric Cancer Patients [J]. Front Cell Dev Biol，2021，9：694673.
[27] Zhang J，Piao HY，Wang Y，et al. To Develop and Validate the Combination of RNA Methylation Regulators for the Prognosis of Patients with Gastric Cancer [J]. Onco Targets Ther，2020，13：10785-10795.
[28] Liu X，Liu L，Dong Z，et al. Expression patterns and prognostic value of m6A-related genes in colorectal cancer [J]. Am J Transl Res，2019，11（7）：3972-3991.
[29] Wang Y，Lu JH，Wu QN，et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer [J]. Mol Cancer，2019，18（1）：174.
[30] Pi J，Wang W，Ji M，et al. YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7 [J]. Cancer Res，2021，81（10）：2651-2665.
[31] Chen XY，Liang R，Yi YC，et al. The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner [J]. Front Cell Dev Biol，2021，9：647702.
[32] Liu T，Yang S，Cheng YP，et al. The N6-Methyladenosine Methylation Gene YTHDF1 Reveals a Potential Diagnostic Role for Gastric Cancer [J]. Cancer Manag Res，2020，12：11953-11964.
[33] Shen X，Zhao K，Xu L，et al. YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway [J]. Front Genet，2021，11：592042.
[34] Zhang B，Wu Q，Li B，et al. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer [J]. Mol Cancer，2020，19（1）：53.
[35] Huang Y，Yan J，Li Q，et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5 [J]. Nucleic Acids Res，2015，43（1）：373-384.
[36] Su R，Dong L，Li C，et al. R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling [J]. Cell，2018，172（1/2）：90-105.
[37] Huang Y，Su R，Sheng Y，et al. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia [J]. Cancer Cell，2019，35（4）：677-691.
[38] Su R，Dong L，Li Y，et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion [J]. Cancer Cell，2020，38（1）：79-96. |
|
|
|
